Search research articles
Contact Us
Filters
Showing results (191-200 of 295) with videos related to
Page
of 30
Sort By:
Neurology
|
January 29, 2017
Frontotemporal dementia with the V337M <i>MAPT</i> mutation: Tau-PET and pathology correlations
Salvatore Spina, Daniel R Schonhaut, Bradley F Boeve, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
January 4, 2026
Defining patient-centered amyloid PET thresholds for the onset of tauopathy in Alzheimer's disease
Zeyu Zhu, Anna Steward, Amir Dehsarvi, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 24, 2025
Biomarkers
Shorena Janelidze, Lyduine E Collij, Niklas Mattsson-Carlgren, et al.
Lancet (London, England)
|
September 25, 2025
New landscape of the diagnosis of Alzheimer's disease
Giovanni B Frisoni, Oskar Hansson, Emma Nichols, et al.
Medrxiv : the Preprint Server for Health Sciences
|
July 9, 2025
Benchmarking the AI-based diagnostic potential of plasma proteomics for neurodegenerative disease in 17,170 people
Lijun An, Alexa Pichet-Binette, Ines Hristovska, et al.
Biorxiv : the Preprint Server for Biology
|
November 19, 2025
Patient-specific functional brain architecture explains cortical patterns of tau PET in Alzheimer's disease
Harry H Behjat, Jacob W Vogel, Olof Strandberg, et al.
Brain : a Journal of Neurology
|
September 18, 2025
Cortical tau deposition promotes atrophy in connected white matter regions in Alzheimer's disease
Julia Pescoller, Anna Dewenter, Amir Dehsarvi, et al.
Medrxiv : the Preprint Server for Health Sciences
|
June 10, 2024
A machine learning-based prediction of tau load and distribution in Alzheimer's disease using plasma, MRI and clinical variables
Linda Karlsson, Jacob Vogel, Ida Arvidsson, et al.
Brain : a Journal of Neurology
|
January 21, 2026
Plasma pTau 217:β-amyloid 1-42 ratio for enhanced accuracy and reduced uncertainty in detecting amyloid pathology
Natalya Benina, Luna Buitrago, Francesca I De Simone, et al.
Alzheimer'S Research & Therapy
|
September 29, 2020
Combination of plasma amyloid beta<sub>(1-42/1-40)</sub> and glial fibrillary acidic protein strongly associates with cerebral amyloid pathology
Inge M W Verberk, Elisabeth Thijssen, Jannet Koelewijn, et al.
Page
of 30
Search research articles
Search
Showing results (191-200 of 295) with videos related to
Sort By:
Page
of 30
Neurology
|
January 29, 2017
Frontotemporal dementia with the V337M <i>MAPT</i> mutation: Tau-PET and pathology correlations
Salvatore Spina, Daniel R Schonhaut, Bradley F Boeve, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
January 4, 2026
Defining patient-centered amyloid PET thresholds for the onset of tauopathy in Alzheimer's disease
Zeyu Zhu, Anna Steward, Amir Dehsarvi, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 24, 2025
Biomarkers
Shorena Janelidze, Lyduine E Collij, Niklas Mattsson-Carlgren, et al.
Lancet (London, England)
|
September 25, 2025
New landscape of the diagnosis of Alzheimer's disease
Giovanni B Frisoni, Oskar Hansson, Emma Nichols, et al.
Medrxiv : the Preprint Server for Health Sciences
|
July 9, 2025
Benchmarking the AI-based diagnostic potential of plasma proteomics for neurodegenerative disease in 17,170 people
Lijun An, Alexa Pichet-Binette, Ines Hristovska, et al.
Biorxiv : the Preprint Server for Biology
|
November 19, 2025
Patient-specific functional brain architecture explains cortical patterns of tau PET in Alzheimer's disease
Harry H Behjat, Jacob W Vogel, Olof Strandberg, et al.
Brain : a Journal of Neurology
|
September 18, 2025
Cortical tau deposition promotes atrophy in connected white matter regions in Alzheimer's disease
Julia Pescoller, Anna Dewenter, Amir Dehsarvi, et al.
Medrxiv : the Preprint Server for Health Sciences
|
June 10, 2024
A machine learning-based prediction of tau load and distribution in Alzheimer's disease using plasma, MRI and clinical variables
Linda Karlsson, Jacob Vogel, Ida Arvidsson, et al.
Brain : a Journal of Neurology
|
January 21, 2026
Plasma pTau 217:β-amyloid 1-42 ratio for enhanced accuracy and reduced uncertainty in detecting amyloid pathology
Natalya Benina, Luna Buitrago, Francesca I De Simone, et al.
Alzheimer'S Research & Therapy
|
September 29, 2020
Combination of plasma amyloid beta<sub>(1-42/1-40)</sub> and glial fibrillary acidic protein strongly associates with cerebral amyloid pathology
Inge M W Verberk, Elisabeth Thijssen, Jannet Koelewijn, et al.
Page
of 30